Nectar Lifesciences Statistics

Total Valuation

Nectar Lifesciences has a market cap or net worth of EUR 86.00 million. The enterprise value is 154.55 million.

Market Cap	86.00M
Enterprise Value	154.55M

Important Dates

The last earnings date was Tuesday, November 12, 2024.

Earnings Date	Nov 12, 2024
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+2.93%
Shares Change (QoQ)	-1.94%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	85.87M

Valuation Ratios

The trailing PE ratio is 74.92.

PE Ratio	74.92
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	0.78
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.90, with an EV/FCF ratio of 10.57.

EV / Earnings	134.63
EV / Sales	0.82
EV / EBITDA	7.90
EV / EBIT	12.16
EV / FCF	10.57

Financial Position

The company has a current ratio of 1.31, with a Debt / Equity ratio of 0.58.

Current Ratio	1.31
Quick Ratio	0.41
Debt / Equity	0.58
Debt / EBITDA	3.61
Debt / FCF	4.61
Interest Coverage	1.24

Financial Efficiency

Return on equity (ROE) is 1.00% and return on invested capital (ROIC) is 4.10%.

Return on Equity (ROE)	1.00%
Return on Assets (ROA)	3.27%
Return on Capital (ROIC)	4.10%
Revenue Per Employee	106,585
Profits Per Employee	681
Employee Count	1,686
Asset Turnover	0.78
Inventory Turnover	1.67

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +8.84% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+8.84%
50-Day Moving Average	0.46
200-Day Moving Average	0.43
Relative Strength Index (RSI)	34.66
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Nectar Lifesciences had revenue of EUR 179.70 million and earned 1.15 million in profits. Earnings per share was 0.01.

Revenue	179.70M
Gross Profit	54.64M
Operating Income	12.12M
Pretax Income	2.91M
Net Income	1.15M
EBITDA	18.65M
EBIT	12.12M
Earnings Per Share (EPS)	0.01

Full Income Statement

Balance Sheet

The company has 2.00 million in cash and 67.32 million in debt, giving a net cash position of -65.32 million.

Cash & Cash Equivalents	2.00M
Total Debt	67.32M
Net Cash	-65.32M
Net Cash Per Share	n/a
Equity (Book Value)	115.34M
Book Value Per Share	0.52
Working Capital	32.98M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 16.99 million and capital expenditures -2.37 million, giving a free cash flow of 14.62 million.

Operating Cash Flow	16.99M
Capital Expenditures	-2.37M
Free Cash Flow	14.62M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 30.40%, with operating and profit margins of 6.74% and 0.64%.

Gross Margin	30.40%
Operating Margin	6.74%
Pretax Margin	1.62%
Profit Margin	0.64%
EBITDA Margin	10.38%
EBIT Margin	6.74%
FCF Margin	8.13%

Dividends & Yields

Nectar Lifesciences does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.93%
Shareholder Yield	-2.93%
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a